Roobsoong Wanlapa
Mahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol University, 420/6 Ratchawithi Road, Ratchathewi, Bangkok, 10400, Thailand.
Methods Mol Biol. 2015;1325:187-96. doi: 10.1007/978-1-4939-2815-6_15.
Plasmodium vivax is considered as the most widely distributed human malaria parasite outside Africa. Studies of P. vivax malaria have always been limited due to the lack of continuously in vitro-propagated parasite lines. Due to this limitation, studies on P. vivax have lagged behind that of P. falciparum, which is routinely maintained in in vitro blood-stage culture. This method allows for the short-term ex vivo culture of P. vivax blood stages and as such offers a wealth of opportunities to study the biology of the blood stages of the parasite. In this chapter we describe the in vitro erythrocyte invasion inhibition assay (IIA) for P. vivax, which can be used as a powerful tool for blood-stage vaccine screening. The major challenges of this assay are the purification of schizont-stage parasites and host reticulocytes. The purification methods for both P. vivax schizont-stage parasites and reticulocytes as detailed here have been developed and simplified. The protocols in this chapter have been optimized to ensure that IIA becomes a more feasible and reliable assay.
间日疟原虫被认为是非洲以外分布最广泛的人类疟原虫。由于缺乏持续体外培养的寄生虫株,对间日疟原虫疟疾的研究一直受到限制。由于这一限制,间日疟原虫的研究落后于恶性疟原虫,后者可在体外血液阶段常规培养。该方法允许对间日疟原虫血液阶段进行短期离体培养,因此为研究该寄生虫血液阶段的生物学特性提供了大量机会。在本章中,我们描述了用于间日疟原虫的体外红细胞入侵抑制试验(IIA),它可作为血液阶段疫苗筛选的有力工具。该试验的主要挑战是裂殖体阶段寄生虫和宿主网织红细胞的纯化。此处详细介绍的间日疟原虫裂殖体阶段寄生虫和网织红细胞的纯化方法已经得到开发和简化。本章中的方案已经优化,以确保IIA成为一种更可行、更可靠的试验。